# A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

> **NCT00242008** · PHASE3 · COMPLETED · sponsor: **UCB Pharma**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine

## Key facts

- **NCT ID:** NCT00242008
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** — (—)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242008, "A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00242008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*